(EMAILWIRE.COM, November 30, 2018 ) The global cardiac ablation catheters market is poised to grow at a CAGR of 11.5% during 2016-2021. Although the mature markets (such as the U.S., Germany, France, and U.K.) hold larger shares in the cardiac ablation catheters market, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. The growth of the cardiac ablation catheters market is driven by factors such as growing geriatric population coupled with an increasing population base of cardiovascular disease patients, ongoing technological advancements in the field of cardiac ablation catheters products, increasing demand for minimally invasive cardiac treatment procedures, and growing awareness about benefits of cardiac ablation procedures over conventional therapeutic and surgical procedures. However, factors such as cost-containment measures taken by various governments and ongoing healthcare reforms in the U.S. are restraining the growth of this market. Therapeutic challenges related to ablation procedures and stringent regulatory guidelines leading to significant increase in gestation period of product launches is posing a significant challenge for the growth of the cardiac ablation catheters market.

In this report, the global cardiac ablation catheters market has been segmented on the basis of type of technology (radiofrequency, electrical, cryoablation, ultrasound, and microwave ablation technologies), product (radiofrequency ablators, electrical ablators, cryoablation devices, ultrasound ablators, and microwave ablators), and type of application (cardiac rhythm management, open surgery, and others). The radiofrequency ablation technology segment accounted for the largest share of the global cardiac ablation market in 2014, followed by the electrical ablation technology market. Factors such as rising awareness regarding application of radiofrequency ablation in cardiac treatment, presence of large number of radiofrequency ablation centers across the region, and low procedural cost of radiofrequency-based cardiac ablation are driving the growth of the market.

Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the global cardiac ablation catheters market in 2016, followed by Europe. The cardiac ablation catheters market in the North America is primarily driven by factors such as presence of large number of ablation centers, increasing installation base of advanced cardiac ablation catheters, increasing demand for minimally invasive cardiac treatment procedures, and growing awareness about the benefits of ablation procedures over conventional therapeutic and surgical procedures. However, Asia-Pacific region is poised to grow at the highest CAGR during next five years, owing to factors such as large patient population base, growing government support to increase public access for advanced therapeutic and surgical procedures, and strengthening healthcare infrastructure across the region.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=44098491

The global cardiac ablation catheters market is moderately competitive with a various global as well as local market players. As of 2015, the global cardiac ablation catheters market was dominated by Medtronic Plc (U.S.), AtriCure, Inc. (U.S.), Biosense Webster Inc. (U.S.), Boston Scientific Corporation (U.S.), and St Jude Medical, Inc. (U.S.). New product launches, partnerships, agreements, and collaborations, and strategic acquisitions are the major strategies adopted by most of the market players to achieve growth in the global cardiac ablation catheters market.